"Lower down the market biotechnology group CeNeS jumped 20.5p to 52.5p as it revealed it had received a bid approach. US groups Endo and Purdue Pharmaceuticals were mentioned as possible bidders."
http://www.guardian.co.uk/money/2008/feb/06/property.hsbcholdingsbusiness
Wednesday, February 6, 2008
CEN
